Risk of thromboembolism in new onset or transient atrial fibrillation

Progress in Cardiovascular Diseases

Volumn 39, Issue 1, 1996, Pages 69-80

  Stoddard, M F ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ANIMAL MODEL; ANTICOAGULANT THERAPY; CARDIOVERSION; CLINICAL TRIAL; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PATHOGENESIS; REVIEW; RISK ASSESSMENT; STROKE; THROMBOEMBOLISM; THROMBOGENESIS;

EID: 0029776434     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-0620(96)80042-9     Document Type: Article

References (67)

1. Ostrander LD Jr Brandt RL Kjeisberg MO Eiectrocardiographic findings among the adult-population of a total natural community, Tecumsch, Michigan Circulation 31 1965 888 898
2. Orndahl G Thulesius O Hood B Incidence of persistent atrial fibrillation and conduction defects in coronary heart disease Am Heart J 84 1972 120 131
3. Wolf PA Abbott RD Kannel WB Atrial fibrillation: A major contributor to stroke in the elderly—the Framingham study Arch Intern Med 147 1987 1561 1564
4. Petersen P Godtfrendsen J Atrial fibrillation: A review of course and prognosis Acta Med Scand 216 1984 5 9
5. Cameron A Schwartz MJ Kranmal RA Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry) Am J Cardiol 61 1988 714 717
6. Yamanouchi H Tomonaga M Shimada H Nonvalvular atrial fibrillation as a cause of fatal massive cerebral infarction in the elderly Stroke 20 1989 1653 1656
7. Wolf PA Dawber TR Thomas E Epidemiologic assessment of chronic fibrillation and risk of stroke: The Framingham Study Neurology 28 1978 973 977
8. Petersen P Thromboembolic complications in atrial fibrillation Stroke 21 1990 4 13
9. Cairns JA Connolly SJ Nonrheumatic atrial fibrillation Circulation 84 1991 469 481
10. Pritchett ELC Management of atrial fibrillation N Engl J Med 326 1992 1264 1271
11. Petersen P Boysen G Godtfredsen J Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASAK Study Lancet 1 1989 175 179
12. Boston Area Anticoagulation Trial for Atrial Fibrillation The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation N Engl J Med 323 1990 1505 1511
13. Connolly SJ Laupacis A Gent M Canadian Atrial Fibrillation Anticoagulation (CAFA) Study J Am Coll Cardiol 18 1991 349 355
14. Stroke Prevention in Atrial Fibrillation Investigators Stroke Prevention in Atrial Fibrillation Study: Final results Circulation 84 1991 527 539
15. Ezekowitz MD Bridgers SL James KE Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation N Engl J Med 327 1992 1406 1412
16. Bjerkelund CJ Orning OM The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation Am J Cardiol 23 1969 208 216
17. Roy D Marchand E Gagne P Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation Am Heart J 112 1986 1039 1043
18. Weinberg DM Mancini JCB Anticoagulation for cardioversion of atrial fibrillation Am J Cardiol 63 1989 745 746
19. Arnold AZ Mick MJ Mazurek RP Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter J Am Coll Cardiol 19 1992 851 855
20. Manning WJ Silverman DI Gordon SPF Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi N Engl J Med 328 1993 750 755
21. Black IW Hopkins AP Lee LCL Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients Am Heart J 126 1993 375 381
22. Orsinelli DA Pearson AC Usefulness of transesophageal echocardiography to screen for left atrial thrombus before elective cardioversion for atrial fibrillation Am J Cardiol 72 1993 1337 1339
23. Stoddard MF Dawkins PR Prince CR Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation Am Heart J 129 1995 1204 1215
24. Manning WJ Silverman DI Keighley CS Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: Final results of a prospective 4.5-year study J Am Coll Cardiol 25 1995 1354 1361
25. Grimm RA Steward WJ Malone JD Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: Characterization by simultaneous transesophageal echocardiography J Am Coll Cardiol 22 1993 1359 1366
26. Fatkin D Kuchar DL Thorburn CW Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: Evidence for “atrial stunning” as a mechanism of thromboembolic complications J Am Coll Cardiol 23 1994 307 316
27. Daniel WG Nellessen U Schroder E Left atrial spontaneous echo contrast in mitral valve disease: An indicator for an increased thromboembolic risk J Am Coll Cardiol 11 1988 1204 1211
28. Beppu S Nimura Y Sakakibara H Smoke-like echo in the left atrial cavity in mitral valve disease: Its features and significance J Am Coll Cardiol 6 1985 744 749
29. Castello R Pearson AC Labovitz AJ Prevalence and clinical implications of atrial spontaneous contrast in patients undergoing transesophageal echocardiography Am J Cardiol 65 1990 1149 1153
30. Black IW Fatkin D Sagar KB Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation Circulation 89 1994 2509 2513
31. De Silva RA Graboys TB Podrid PJ Cardioversion and defibrillation Am Heart J 100 1980 881 895
32. (suppl) Laupacis A Albers G Dunn M Antithrombotic therapy in atrial fibrillation Chest 102 1992 426S 433S
33. Fisher CM Reducing risks of cerebral embolism Geriatrics 34 1979 59 66
34. Sherman DG Goldman L Whiting RB Thromboembolism in patients with atrial fibrillation Arch Neurol 41 1984 708 710
35. Wolf PA Kannel WB McGee DL Duration of atrial fibrillation and eminence of stroke: The Framingham Study Stroke 14 1983 664 667
36. Petersen P Godtfredsen J Embolic complications in paroxysmal atrial fibrillation Stroke 17 1986 622 627
37. Takahashi N Seki A Imataka K Clinical features of paroxysmal atrial fibrillations: An observation of 94 patients Jpn Heart J 22 1981 143 149
38. Shimomura K Ohe T Ueharas S Significance of atrial fibrillation as a precursor of embolism Am J Cardiol 63 1989 1405 1407
39. Kelly RE Berger JR Alter M Cerebral ischemia and atrial fibrillation: Prospective study Neurology 34 1984 1285 1291
40. Hart RG Coull BM Hart D Early recurrent embolism associated with nonvalvular atrial fibrillation: A retrospective study Stroke 14 1983 688 693
41. Darling RC Austen WG Linton RR Arterial embolism Surg Gynecol Obstet 124 1987 106 114
42. Rothrock JF Dittrich HC McAllen S Acute anticoagulation following cardioembolic stroke Stroke 20 1989 730 734
43. (abstr) McIlraith DM Côté R Wolfson C Acute cerebral infarction in non-valvular atrial fibrillation: Early recurrence of stroke and other ischemic events Stroke 21 1990 174
44. Uno M Tsuji H Sawada S Fibrinopeptide A (FPA) levels in atrial fibrillation and the effects of heparin administration Jpn Circ J 52 1988 9 12
45. Gustafsson C Blomback M Britton M Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation Stroke 21 1990 47 51
46. Kumagi K Fukunami M Ohmori M Increased intracardiovascular clotting in patients with nonvalvular atrial fibrillation J Am Coll Cardiol 16 1990 377 380
47. Stein B Fuster V Halperin JL Antithrombotic therapy in cardiac disease. An emerging approach based on pathogenesis and risk Circulation 80 1989 1501 1513
48. Hochman JS Platia EB Bulkley BH Endocardial abnormalities in left ventricular aneurysms: a clinicopathologic study Ann Intern Med 100 1984 29 35
49. Fuster V Halperin JL Left ventricular thrombi and cerebral embolism an emerging approach N Engl J Med 320 1989 392 394
50. Manning WJ Leeman DE Gotch PJ Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation J Am Coll Cardiol 13 1989 617 623
51. Goldman MJ The management of chronic atrial fibrillation: Indications for and method of conversion to sinus rhythm Prog Cardiovasc Dis 2 1960 465 479
52. Stoddard MF Dawkins PR Prince CR Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographic study J Am Coll Cardiol 25 1995 452 459
53. Mügge A Daniel WG Hausmann D Diagnosis of left atrial appendage thrombi by transesophageal echocardiography: Clinical implications and follow-up Am J Card Imaging 4 1990 173 179
54. Manning WJ Silverman DI Waksmonski CA Prevalence of residual left atrial thrombi among patients with acute thromboembolism and Newly recognized atrial fibrillation Arch Intern Med 155 1995 2193 2198
55. Pollick C Taylor D Assessment of left atrial appendage function by transesophageal echocardiography: Implications for the development of thrombus Circulation 84 1991 223 231
56. Pozzoli M Febo O Torbicki A Left atrial appendage dysfunction a cause of thrombosis? evidence by transesophageal echocardiography-Doppler studies J Am Soc Echocardiogr 4 1991 435 441
57. García-Fernández MA Torrecilla EG Roman DS Left atrial appendage Doppler flow patterns—Implications on thrombus formation Am Heart J 124 1992 955 960
58. Verhorst PMJ Kamp O Visser CA Left atrial appendage flow velocity assessment using transesophageal echocardiography in nonrheumatic atrial fibrillation and systemic embolism Am J Cardiol 71 1993 192 196
59. Mügge A Kühn H Nikutta P Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: Identification of a subgroup of patients at increased embolic risk J Am Coll Cardiol 23 1994 599 607
60. Fatkin D Kelly RP Feneley MP Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo J Am Coll Cardiol 23 1994 961 969
61. Hoit BD Shao Y Gabel M Influence of acutely altered loading conditions on left atrial appendage flow velocities J Am Coll Cardiol 24 1994 1117 1123
62. Leung DYC Black IW Cranney GB Prognostic implications of left atrial spontaneous echo contrast in nonvalvular fibrillation J Am Coll Cardiol 24 1994 755 762
63. Grimm RA Leung DY Black IW Left atrial appendage “stunning” after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography Am Heart J 130 1995 174 176
64. Black IW Hopkins AP Lee LCL Left atrial spontaneous echo contrast a clinical and echocardiographic analysis J Am Coll Cardiol 18 1991 398 404
65. Blackshear JL Pearce LA Asinger RW Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation Am J Cardiol. 72 1993 840 843
66. Movsowitz C Movsowitz HD Jacobs LE Significant mitral regurgitation is protective against left atrial spontaneous echo contrast and thrombus as assessed by transesophageal echocardiography J Am Soc Echocardiogr 6 1993 107 114
67. Prystowsky EN Benson DW Fuster V Management of patients with atrial fibrillation: A statement for healthcare professionals from the subcommittee on electrocardiography and electrophysiology, American Heart Association Circulation 93 1996 1262 1277